TRDA logo

Entrada Therapeutics, Inc.

TRDA
Healthcare|Biotechnology|US
$4.89
+0.34 (+7.47%)
DCF Value
$9.63
Tangible Book / Share
$4.68
Cash / Share
$4.56
Next Earnings Report
Feb 25, 2027
EPS est. -$1.01 · Revenue est. $3.0M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (2)

Mar 2029
Est. completion
P1P2Duchenne Muscular Dystrophy (DMD)
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
NCT07038824n=24
Mar 2029
Est. completion
P1P2Duchenne Muscular Dystrophy (DMD)
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
NCT07037862n=24

Recent Press Releases

Entrada Therapeutics Reports Third Quarter 2026 Financial Results
Nov 5, 2026 · GlobeNewsWire
Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer
Oct 21, 2026 · GlobeNewsWire
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics' ELEVATE-44-201 Study
Oct 14, 2026 · GlobeNewsWire
Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45
Oct 14, 2026 · GlobeNewsWire
Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program
Sep 10, 2026 · GlobeNewsWire
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 2, 2026 · GlobeNewsWire

SEC Filings (52)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Oct 14, 20268-KMaterial eventDocumentIndex
Sep 10, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 5, 202610-QQuarterly reportDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Jun 10, 20268-KMaterial eventDocumentIndex
May 19, 20268-KMaterial eventDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
Apr 29, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 24, 2026ARSAnnual report to holdersDocumentIndex
Apr 24, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 24, 2026DEF 14AProxy / shareholder voteDocumentIndex
Feb 26, 2026S-8Employee stock planDocumentIndex
Feb 26, 202610-KAnnual reportDocumentIndex
Feb 26, 20268-KMaterial eventDocumentIndex
Jan 8, 20268-KMaterial eventDocumentIndex
Dec 3, 2025EFFECTDocumentIndex
Nov 25, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 18, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 6, 2025S-3Shelf registrationDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 6, 202510-QQuarterly reportDocumentIndex
Aug 6, 20258-KMaterial eventDocumentIndex
Jun 11, 20258-KMaterial eventDocumentIndex
Jun 3, 2025DEFA14AProxy / shareholder voteDocumentIndex
Jun 3, 20258-KMaterial eventDocumentIndex
May 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 8, 202510-QQuarterly reportDocumentIndex
May 8, 20258-KMaterial eventDocumentIndex
Apr 29, 20258-KMaterial eventDocumentIndex
Apr 25, 2025ARSAnnual report to holdersDocumentIndex
Apr 25, 2025DEFA14AProxy / shareholder voteDocumentIndex
Apr 25, 2025DEF 14AProxy / shareholder voteDocumentIndex